Wyszogrodzka-Kucharska Anna, Rabe-Jabłońska Jolanta
Klinika Zaburzeń Afektywnych i Psychiatrii Młodziezowej Uniwersytetu Medycznego w Lodzi.
Przegl Lek. 2006;63(3):134-8.
The etiopathogenesis, risk factors and indications for prevention and treatment of osteoporosis in patients with schizophrenia are presented. Accelerated decrease in bone mineral density (BMD) is mostly attributed to antypsychotics (drug-induced hyperprolactinemia and decrease in levels of estrogen and testosterone), insufficient calcium intake, low physical activity and limited exposure to sunshine, alcohol and tobacco intake, polidypsia. Clinical symptoms of osteoporosis (eg. vertebral fractures) develop very slowly and in patients with schizophrenia are very rarely diagnosed. Many of risk factors (especially adequate choice of pharamcotherapy and monitoring of BMD) might be prevented in order to decrease the prevalence of osteoporosis in population of patients with schizophrenia.
本文介绍了精神分裂症患者骨质疏松症的病因、危险因素以及预防和治疗指征。骨矿物质密度(BMD)加速下降主要归因于抗精神病药物(药物性高催乳素血症以及雌激素和睾酮水平降低)、钙摄入不足、体力活动少、日照有限、饮酒和吸烟、多饮。骨质疏松症的临床症状(如椎体骨折)发展非常缓慢,在精神分裂症患者中很少被诊断出来。许多危险因素(尤其是合理选择药物治疗和监测骨密度)是可以预防的,以降低精神分裂症患者群体中骨质疏松症的患病率。